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Amyloid ﬁbrils are highly ordered crystal-like structures. It is generally assumed that individual
amyloid ﬁbrils consist of conformationally uniform cross-b-sheet structures that enable the amy-
loids to replicate their individual conformations via a template-dependent mechanism. Recent stud-
ies revealed that amyloids are capable of accommodating a global conformational switch from one
amyloid strain to another within individual ﬁbrils. The current review highlights the high adapta-
tion potential of amyloid structures and discusses the implication of these ﬁndings for several
emerging issues including prion strain adaptation (i.e. gradual change in strain structure). It also
proposes that the catalytic activity of an amyloid structure should be separated from its templating
effect, and raises the question of strain classiﬁcation according to their promiscuous or species-spe-
ciﬁc nature.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction amyloid structures and have numerous implications for our under-Amyloid ﬁbrils are highly-ordered, densely packed and thermo-
dynamically stable protein structures [1,2] that are believed to be a
common state of a polypeptide backbone [3]. Despite the large
diversity in ﬁbril morphology [4], the key structural components
in amyloid ﬁbrils and amyloid-like structures have similar archi-
tecture in which the individual b-strands are assembled perpendic-
ular to the ﬁbrillar axis and separated by a distance of 4.8 Å,
forming the so-called cross-b core [5]. Considering that the ﬁbrils
are highly ordered crystal-like structures, the conformation of a
cross-b core is believed to be structurally uniform within individ-
ual ﬁbrils. Although conformationally different amyloids can be
formed within the same amino acid sequence [6,7], structural uni-
formity of individual ﬁbrils enables faithful copying of the confor-
mation from the parent molecules in a ﬁbril to newly recruited
daughter molecules. The principle of template-dependent ampliﬁ-
cation is believed to underlie the self-replicating mechanism of
prion propagation and protein-based memory or inheritance [8–
10] (Fig. 1A). Recent studies, however, revealed that amyloid struc-
tures are capable of substantial conformational changes that can be
observed even within individual ﬁbrils [11]. These unexpected
ﬁndings highlight the high adaptation potential of seemingly rigidchemical Societies. Published by E
o, mouse; PK, proteinase K
1, USA. Fax: +1 410 706 8184.standing of structural and functional properties of amyloids and
prions.
2. Current view of template-dependent amyloid replication
The self-replicating properties of amyloid ﬁbrils are attributed
to the unique assembly of the amyloid cross-b-core. Because of
the perpendicular arrangement of b-strands relative to the ﬁbrillar
axis, they provide a template for recruiting and converting a mono-
meric precursor at the growing edge. The self-replicating process
consists of two activities: (i) catalytic (which is deﬁned as the abil-
ity of amyloid state to recruit and facilitate conversion of a mono-
meric precursor into an amyloid state), and (ii) templating (i.e. the
ability to accurately imprint the strain-speciﬁc conformation onto
a newly recruited polypeptide). A balance between template-
dependent elongation and ﬁbril fragmentation provides an effec-
tive mechanism for multiplication of seeds resulting in self-replica-
tion of the amyloid state at the expense of the monomeric state of a
protein [12] (Fig. 1A).
The templating and catalytic activities of amyloid are believed
to be intimately coupled. Faithful templating is based on self-com-
plementation of a polypeptide chain involved in amyloid assembly
[13]. Self-complementation can be achieved trough several mech-
anisms including tight complementarity of amino acid side chains
in the sterric zippers of the cross-b spine; the stacking of side







Fig. 1. Schematic representation amyloid replication. (A) Conventional template-
dependent model illustrates that alternative self-replicating amyloid structures
could be formed within the same amino acid sequence and that each structure
faithfully replicates itself through fragmentation and elongation. (B) Cross-seeded
ﬁbrillations. When seeded by a promiscuous amyloid strain, a heterologous variant
adopts the same conformation as the conformation of seeds resulting in ﬁbrils,
which are hybrid with respect to their composition (i). When seeded by a species-
speciﬁc amyloid strain, the heterologous variant is also involved in elongation,
however, it acquires a new conformation. The newly formed ﬁbrils are hybrid with
respect to their composition and conformation (ii).
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main swapping [13].
Although multiple amyloid structures could be produced within
the same amino acid sequence [6,7], only structures with high
ﬁdelity of replication maintain their strain-speciﬁc properties
through multiple rounds of replication. It is yet to be determined
what classes of amyloids display high ﬁdelity of replication and
whether speciﬁc structural motifs account for the high ﬁdelity.
3. Switch in an amyloid strain within individual ﬁbrils
The recent studies that employed single-ﬁbril microscopy imag-
ing revealed that the elongation of ﬁbrils does not always support
uniformity in the cross-b structure within individual ﬁbrils
[7,11,14]. In these studies, two amyloid strains referred to as S-
and R-ﬁbrils were produced in vitro from highly pure hamster
(Ha) recombinant prion protein (rPrP) [7]. In order to determine
whether individual strain-speciﬁc conformations were maintained
in the cross-seeding reactions, Ha S- and R-strains were used for
cross-seeding the ﬁbrillation of the closely-related mouse (Mo)
rPrP [11,14]. It is important to emphasize that the original Ha S-
and R-ﬁbrils showed fundamentally different global folds, includ-
ing differences in the structures of their cross-b-cores [7,15]. Ha
R-ﬁbrils were able to elongate using Mo rPrP as a substrate while
replicating their R-conformation faithfully despite utilizing a het-
erologous rPrP variant [14] (Fig. 1B). Surprisingly, Ha S-ﬁbrils also
recruited Mo rPrP; however, the ﬁbril elongation proceeded
through switching to a new conformational state that resembled
the R-conformation [11] (Fig. 1B). Despite the lack of compatibility
between Mo rPrP amino acid sequence and S-structure, the Ha S-
template was as efﬁcient in recruiting Mo rPrP molecules as the
Ha R-template that was fully compatible with the Mo rPrP amino
acid sequence (the term ‘‘compatibility” is deﬁned here as the abil-
ity of a PrP variant to acquire certain strain-speciﬁc conformation).
Unexpectedly, the cross-seeding reaction produced hybrid ﬁbrils
that were formed by two segments each of which was composedby one of two rPrP variants (Ha or Mo), and each of which adopted
a unique, clearly distinctive conformation within its own segment.
A separate set of experiments revealed that Mo rPrP was not able
to adopt the S-structure that appeared to be Ha-speciﬁc [11].
Therefore, the switch from S- to R-conformation within hybrid ﬁ-
brils occurred due to the inability of the recruited Mo rPrP precur-
sor to acquire the S-conformation of the ﬁbrillar template.4. Separating templating and catalytic activities
The catalytic and templating activities, the two key features of
the amyloid and prion replication, were believed to be intimately
coupled owing to the self-replicating nature of the cross-b struc-
ture [8]. The experiment on cross-seeding of Mo rPrP using two
Ha amyloid strains revealed that amyloid structures can display
catalytic activity in the absence of a templating effect [11].
The ability to seed ﬁbrillation reactions without transferring
seed-speciﬁc structure in not limited to the replication of amyloids
formed from recombinant polypeptides. In two recently developed
assays, miniscule amounts of PrPSc were found capable of seeding
the ﬁbrillation of rPrPs [16,17]. As judged from the proteinase K
(PK)-resistance proﬁle, however, the products of PrPSc-seeded con-
version did not mimic the structure of infectious PrPSc but were
similar to the rPrP ﬁbrils produced in the non-seeded reactions
or in the reactions seeded with rPrP amyloids [18]. Surprisingly,
regardless of whether PrPSc or rPrP amyloids were used as seeds,
all conversion products formed from rPrPs showed the major PK-
resistant fragments in the range between 10 and 13 kDa. Therefore,
when rPrP was supplied as a substrate, PrPSc maintained its seed-
ing activity, but failed to transfer its PrPSc-speciﬁc infectious con-
formation to rPrP. To date, formation of infections prions from
rPrP in PrPSc-seeded reactions including the Protein Misfolding
Cyclic Ampliﬁcation reaction has not been demonstrated and re-
mains one of the most puzzling problems in the ﬁeld. Why does
PrPSc lack the templating effect when used with rPrP substrate or
why does rPrP fail to acquire an infectious conformation in PrPSc-
driven conversion?
In a search for possible answers we need to discuss the PrP en-
ergy landscape. First of all, the structure of rPrP amyloid ﬁbrils is
fundamentally different from that of PrPSc [19]. Second, rPrP ﬁbrils
are much more thermodynamically stable than any known PrPSc
strains [20–22]. Third, the structural variations between different
PrPSc strains are relatively minor [23,24] when compared to the
differences between structures of PrPSc and in vitro formed rPrP
amyloids [7]. Therefore, the amyloid state appears to correspond
to a global energetic minimum in the PrP energy landscape,
whereas the PrPSc states occupy local energy minima (Fig. 2). The
reverse correlation between the conformational stability of PrPSc
strains and the incubation time to the disease observed in recent
studies [25] highlights the idea that PrPSc structure evolved to
propagate efﬁciently within the complex environment of a cell
and cause disease within an animal’s life time [26]. From a thermo-
dynamic perspective of the prion conversion reactions, PrPSc seeds
decrease the kinetic barriers for the conversion of both substrates,
PrPC and rPrP (Fig. 2). In the reactions involving PrPC, however, the
structure of the end-products is determined by the structure of
PrPSc seeds, whereas in the reactions involving rPrP the ﬁnal prod-
ucts are formed according to global minima in the energy
landscape.
In contrast to PrPC, rPrP lacks posttranslational glycosylation
and a GPI anchor, none of which however were shown to be essen-
tial for acquiring the infectious conformation. Infection of trans-
genic mice expressing GPI-deﬁcient PrPC was found to produce
GPI-anchorless PrPSc deposits that were fully infectious [27]. In









Fig. 2. Energy landscape of prion conversion. The conformational transitions from
rPrP to an amyloid state (A) or from PrPC to PrPSc (B) are separated by a large
energetic barrier that can be reduced by seeding with PrPSc (dotted lines). When
PrPC is used as a substrate, the structure and the conformational stability of the
conversion products are controlled by the strain-speciﬁc features of PrPSc seeds (B).
If rPrP is used as a substrate, the physical properties of the conversion products are
regulated by the free energy landscape (A).
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cosylated PrPSc that could be further transmitted to wild type mice
[28]. The failure of rPrP to acquire an infectious conformation could
be due to its inadequate conformation of peptidyl–prolyl bonds.
The peptidyl–prolyl bonds in proteins can adopt either the cis or
trans conformation with the trans conformation being predomi-
nant. The cis/trans isomerization in mammalian cells was found
to be under strict regulation by the peptidyl–prolyl isomerases
(PPIases) [29]. Full-length PrP has 16 proline residues, where the
residues P101 and P105 seem to have the most dramatic impact
on the ability of PrP to aggregate into the PrPSc-like form [30]. It
is possible that rPrP is substantially different from PrPC with re-
spect to the conformation of the proline backbone and/or distribu-
tion of cis versus trans prolines along the PrP polypeptide chain.
Such differences could be due to (i) the high level of rPrP expres-
sion in Escherichia coli, (ii) the seclusion of rPrP in inclusion bodies
or (iii) an inadequate level of PPIases in E. coli. Recent studies on b-
microglobulin highlighted the importance of the proline cis/trans
isomerization for in vitro conversion into amyloid ﬁbrils [31].
Regardless of the speciﬁc reasons why rPrP fails to acquire the
infectious conformation in PrPSc-seeded reactions, the aforemen-
tioned studies revealed the ability of PrPSc to convert a rPrP precur-
sor to an amyloid PK-resistant state without transferring PrPSc-
speciﬁc conformations to the newly-converted molecules. The
observations of ‘‘seeding without templating” help to develop a
mechanistic explanation for a number of phenomena including
prion strain conversion and adaptation as will be discussed in
the next sections.
5. Promiscuous and species-speciﬁc amyloid structures
The question of why some prion strains cross the species barrier
efﬁciently while others do not is puzzling and calls for a search for
the structural determinants of strain ‘‘promiscuity” (promiscuous
strains are deﬁned as those that can propagate using PrP variants
from more than one species while maintaining their individual
strain-speciﬁc properties, whereas species-speciﬁc strains propa-
gate only within a single species without change in their strain-
speciﬁc features). The key difference between the promiscuous
and species-speciﬁc strains appears to be in their ability to accom-
modate mismatches in PrP amino acid sequence without confor-
mational changes in their individual structures. Considering that
PrPSc structure might not become available in the near future,
the studies that employ rPrP amyloid strains generated in vitro
are very timely in elucidating the molecular rules that underlie
promiscuity or species-speciﬁcity of the self-replicating proteinstates. The R-amyloid ﬁbrils were shown to be compatible with
at least two rPrP variants, Mo and Ha [14] and, therefore, can be
used as a model for deﬁning the molecular structure of promiscu-
ous amyloid strains. The S-strain, on the other hand, replicated it-
self only within the Ha rPrP amino acid sequence, and as such, it
can be a model of species-speciﬁc amyloid structure.
Although the structure of in vitro-generated rPrP amyloids
might be substantially different from that of PrPSc [19], the
in vitro cross-seeding experiments showed surprising parallels
with the data on interspecies prion transmission of bovine prion
strains, BSE and BASE (bovine spongiform encephalopathy and bo-
vine amyloidotic spongiform encephalopathy, respectively) [32].
Upon serial passages in wild type mice, BSE maintained its individ-
ual strain-speciﬁc characteristics showing a limited, if any, species
barrier, whereas the BASE strain displayed a substantial species
barrier and eventually converted into the BSE strain as judged from
biochemical and neuropathological features [32]. In both experi-
ments on cross-seeding of amyloids in vitro or cross-species prion
transmission in vivo, the replication of species-speciﬁc PrPSc or
amyloid strain using a heterologous PrP variant resulted in a
switching into a more promiscuous self-replicating structure. To
address the phenomenon of strain switching, a ‘‘strain conversion”
model was introduced [8,33]. This model, however, does not an-
swer the questions of how does strain switching occur and whether
one can predict a direction for strain switching or adaptation.
6. How does the structure of cross-b core change within
individual ﬁbril?
The question of how cross-b structure changes without inter-
rupting ﬁbril continuity is not trivial. Here, we postulate that with-
in a hybrid ﬁbril, two segments have different global folds while
sharing common local motifs that account for the integrity of the
hybrid structure (Fig. 3). To satisfy this requirement, the same
polypeptide region should adopt the identical parallel b-strand
conformation within two fundamentally different folding struc-
tures. Because the region that acquires the common b-strand con-
formation is connected by hydrogen bonds to the same region in
the polypeptide molecules above and below, the parallel b-sheet
propagates along the whole length of the ﬁbril despite being part
of two different global folds. Hydrogen bonds running up and
down the common b-sheet provide conformational stability for
the whole hybrid structure. This model proposes that the catalytic
activity in recruiting and converting monomeric precursor into an
alternative amyloid state is due to partial overlap in amyloid
structures.
The molecular determinants for forming a stable hybrid struc-
ture have to be elucidated in future studies. It would be important
to determine next whether the formation of hybrid structures re-
quires a high level of homology within the polypeptide regions that
share a common b-strand conformation. Alternatively, acquiring
identical b-strand conﬁguration by two polypeptide regions
regardless of the level of their homology could be sufﬁcient for
forming hybrid ﬁbrils. Future studies should illustrate whether
the model of hybrid ﬁbrils is valid or whether alternative models
could explain the phenomenon of a conformational switch.7. Adaptation potential of amyloids and the hierarchy of
amyloid strains
The observation of conformational switches within individual
ﬁbrils highlights the high adaptation potential for amyloid struc-
tures. Adaptive conformational switching allows recruitment of
non-identical but homologous polypeptide molecules which other-
wise are not compatible with the existing structure.
Fig. 3. A schematic diagram illustrating conformational switch within individual
ﬁbrils. The hybrid ﬁbril consists of two segments with different global folds. Both
segments share b-strands (red) of identical conformation forming parallel b-sheet.
The ﬁgure is reproduced from Makarava et al. [11].
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may provide a mechanistic explanation for modiﬁcation, adapta-
tion or emergence of new prion strains that are typically observed
upon cross-species prion transmission [33–35]. The studies on
interspecies transmission using PMCA reactions or bioassays in
animals revealed that prion strains have variable adaptation poten-
tial. Some strains are capable of maintaining their individual
strain-speciﬁc properties within a range of PrP amino acid se-
quences, whereas other strains can faithfully replicate only within
a single or closely homologous PrP sequence [32–35]. The work on
cross-seeding of rPrP amyloids provided direct illustration that
self-replicating amyloid structures are not equally selective with
respect to the amino acid sequence of the substrate molecules that
can be recruited for their replication [14]. This difference in selec-
tivity between amyloid strains speciﬁes a direction in which adap-
tation or evolution of amyloid structures or prion strains occurs
upon interspecies transmission. The conformational adaptation is
expected to proceed from highly selective or species-speciﬁc struc-
tures toward promiscuous ones. A switch from a species-speciﬁc to
promiscuous strain presumably occurs when a species-speciﬁc
strain faces a heterologous substrate that is not compatible with
the conformation of the original strain. Therefore, one can predict
that inter-species transmissions could lead to formation of new
promiscuous strains.
The new concept on amyloid adaptation could be useful for
developing mechanistic models for a number of puzzling observa-
tions including conformational switching in amyloids formed
within the same sequence or cross-talk between distant or non-re-
lated amyloidogenic proteins. Using conformation-dependent
luminescent dyes, recent studies reported that changes in confor-
mational states of Ab ﬁbrils occurred within single amyloid pla-
ques formed in a Mo brain [36]. Surprisingly, the plaque centers
were characterized by loosely packed or less-ordered structures
that were found to evolve into more compact or tightly packedstructures toward the plaque periphery. Whether this spatial cen-
trifugal alteration in the conformation of Ab amyloid represents
different stages of plaque growth in vivo is not yet clear. This study,
however, highlights that a continuum of conformational states
could be formed within individual plaques.
There are growing examples of cross-seeding between distant
or unrelated amyloidogenic proteins [37–41]. While the efﬁciency
of cross-seeding between two unrelated amyloidogenic polypep-
tides was found to be quite low in vitro [40], the bioassays on ani-
mals revealed that inoculation of b-pleated ﬁbrils formed by one
protein was sufﬁcient to cause or accelerate the in vivo amyloido-
sis of an unrelated protein [39,41]. It is of particular interest that
the ﬁbrils of non-pathogenic proteins including silk ﬁbrils, curli ﬁ-
brils from E. coli, or amyloids of yeast PrP Sup35 were effective in
accelerating the amyloidosis of amyloid protein A upon injections
into wild type mice [39]. It remains to be determined whether hy-
brid ﬁbrillar structures could be formed by two unrelated proteins
and what level of homology is required for maintaining the integ-
rity of hybrid structures.
The process of amyloid cross-seeding in yeast offers an example
of a functional mechanism that evolved to regulate a transition of
certain yeast prion proteins between prion and non-prion states.
Presence of [PIN+], which is the self-propagating or prion state of
the yeast prion protein Rnq1p, was shown to be essential for induc-
ing the conversion of another yeast prion protein Sup35 into its
prion state, referred to as [PSI+]. Considering that the prion folding
domains of both proteins are rich in asparagine and glutamine res-
idues, their degenerative amino acid sequences seem to evolve for
providing a sufﬁcient level of homology for the direct cross-seed-
ing to be effective [42]. Remarkably, [PIN+] seeds were also found
to be active in seeding ﬁbrillation of huntington protein that con-
tains an abnormally long polyglutamine region [43]. Consistent
with the model of a hybrid ﬁbrils proposed here, the mechanism
of cross-talk between the two yeast prions includes direct recruit-
ment of Sup35 by Rnq1p ﬁbrils [42].8. Concluding remarks and future directions
The current article introduces a new concept of hybrid ﬁbrils
and conformational switching within individual ﬁbrils that pro-
vides a mechanistic explanation for the previously observed phe-
nomena of prion strain adaptation, modiﬁcation or convergence,
as well as the cross-interaction of yeast prions or unrelated amyloi-
dogenic proteins. This model suggests that the catalytic activity of
an amyloid structure should be separated from its templating ef-
fect. It raises the question of strain classiﬁcation according to their
promiscuous or species-speciﬁc nature, and helps to predict a
direction in adaptation of amyloid strains.
Important questions to be addressed in future studies include:
does ﬁbrillar structure switch within individual ﬁbrils made of
the same protein; what is the probability of such spontaneous con-
formational switching, and what role does it play in strain struc-
tural diversity; and what is the extent to which the global
amyloid structure must change to encode a new strain?
The dominant view of amyloids as rigid crystalline-like struc-
tures that can be formed only through assembly of identical poly-
peptide chains will likely be changed in the near future. We
anticipate that amyloids will be viewed as dynamic structures
that are capable of accommodating signiﬁcant conformational
switching and of being hybrid with respect to their composition.
The new view should stimulate future studies on establishing
causative links between cross-seeded amyloidoses of disease-re-
lated proteins, on the functional role of amyloids, and the search
for practical applications of amyloids as biomaterials or smart
nanodevices.
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